Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Comabella

Showing results (61-70 of 263) with videos related to

Pageof 27
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosisRobert Goertsches, Sergio E Baranzini, Carlos Morcillo, et al.
Journal of Neuroinflammation|April 17, 2015
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosisSunny Malhotra, Nicolas Fissolo, Mar Tintoré, et al.
European Journal of Neurology|September 27, 2023
Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patientsLuciana Midaglia, Alex Rovira, Berta Miró, et al.
The American Journal of Pathology|April 28, 2004
Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuliJaime Imitola, Manuel Comabella, Anil K Chandraker, et al.
Annals of Neurology|January 26, 2005
Is optic neuritis more benign than other first attacks in multiple sclerosis?Mar Tintoré, Alex Rovira, Jordi Rio, et al.
Archives of Neurology|August 12, 2009
Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosisManuel Comabella, David W Craig, Carlos Morcillo-Suárez, et al.
Frontiers in Neurology|July 8, 2021
Angiogenin in the Neurogenic Subventricular Zone After StrokeMarina Gabriel-Salazar, Ting Lei, Alba Grayston, et al.
Journal of Neurology|May 20, 2008
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosisManuel Comabella, E Julià, M Tintoré, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2023
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment FailureSunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, et al.
Brain : a Journal of Neurology|November 12, 2024
Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody diseaseOmar Chuquisana, Marianna Spatola, Alessandro Dinoto, et al.
Pageof 27

Showing results (61-70 of 263) with videos related to

Sort By:
Pageof 27
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosisRobert Goertsches, Sergio E Baranzini, Carlos Morcillo, et al.
Journal of Neuroinflammation|April 17, 2015
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosisSunny Malhotra, Nicolas Fissolo, Mar Tintoré, et al.
European Journal of Neurology|September 27, 2023
Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patientsLuciana Midaglia, Alex Rovira, Berta Miró, et al.
The American Journal of Pathology|April 28, 2004
Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuliJaime Imitola, Manuel Comabella, Anil K Chandraker, et al.
Annals of Neurology|January 26, 2005
Is optic neuritis more benign than other first attacks in multiple sclerosis?Mar Tintoré, Alex Rovira, Jordi Rio, et al.
Archives of Neurology|August 12, 2009
Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosisManuel Comabella, David W Craig, Carlos Morcillo-Suárez, et al.
Frontiers in Neurology|July 8, 2021
Angiogenin in the Neurogenic Subventricular Zone After StrokeMarina Gabriel-Salazar, Ting Lei, Alba Grayston, et al.
Journal of Neurology|May 20, 2008
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosisManuel Comabella, E Julià, M Tintoré, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2023
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment FailureSunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, et al.
Brain : a Journal of Neurology|November 12, 2024
Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody diseaseOmar Chuquisana, Marianna Spatola, Alessandro Dinoto, et al.
Pageof 27